SELLAS Life Sciences Group Inc (SLS)

8.78 -0.21  -2.34% NASDAQ Jul 23, 20:00 USD
View Full Chart
Price Chart
View All SLS News

News

View All Events

Events

Date Type Description
08/13/2021 Earnings Results Q2 2021 Earnings Results
06/08/2021 08:30 EST AGM 2021 Annual General Meeting
05/13/2021 Earnings Results Q1 2021 Earnings Results
03/23/2021 Earnings Results Q4 2020 Earnings Results
11/13/2020 Earnings Results Q3 2020 Earnings Results
08/13/2020 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.
  • URL: https://www.sellaslifesciences.com
  • Investor Relations URL: http://investors.galenabiopharma.com/investors/default.aspx
  • HQ State/Province: New York
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Aug. 13, 2021
  • Last Earnings Release: May. 13, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.